GulfBase Live Support
24/12/2017 06:18 AST
National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a rights issue. The company has received approval from the Capital Market Authority (CMA) for the rights issue and accordingly, 50 million shares will be issued to the existing shareholders at a price of 102 baisas per share.
The board of directors of the company approved a proposal to raise of the company's capital from OMR5 million to OMR10 million.
The CMA approved the rights issue prospectus based on the request of the company's management and in compliance with all the requirements of the issue.
Times of Oman
| Ticker | Price | Volume |
|---|
23/01/2026
As part of its commitment to actively taking part in raising awareness and promoting financial inclusion and culture among all society segments, National Bank of Kuwait continues to support the banki
Kuwait Times
23/01/2026
AlRayan Bank released yesterday its consolidated financial statements for the year ended December 31, 2025 with net profit attributable to the equity holders of the bank of QR1,530m.
The res
The Peninsula
23/01/2026
Oman Agriculture Development Company today opened Nizwa Dates Industrial Complex. This strategic project serves as an example of investments that generate direct economic value and social impact and
Times of Oman
23/01/2026
Global oil ?glut predictions are seriously exaggerated ?as demand growth ?remains strong and global oil stocks are ?depleted, Amin Nasser, chief executive ?of Aramco, the world's biggest ?oil produce
Reuters
23/01/2026
Kuwait Airways said on Thursday it will launch 11 new destinations for its summer 2026 season, including Alexandria, Zurich, Mykonos, Malaga, Sharm El Sheikh, Salalah, Antalya, Trabzon, Sarajevo, Vie
Gulfnews